NCT07181044

Brief Summary

Background: Regular physical activity exerts systemic health benefits that extend to redox homeostasis and antioxidant defense mechanisms. Ischemia-modified albumin (IMA) and total sulfhydryl groups (-SH) are increasingly recognized as sensitive biomarkers reflecting oxidative protein modification and thiol-dependent antioxidant capacity, respectively. However, data on their interplay in young women engaged in structured exercise remain scarce. Objective: This study aimed to investigate the effects of regular exercise on serum IMA and -SH concentrations in healthy young women, thereby providing insights into exercise-induced redox remodeling and sex-specific physiological adaptations. Methods: A cross-sectional design was employed involving 30 healthy women aged 18-25 years. Participants were divided into an exercise group (n = 15), who had performed structured training ≥3 sessions per week for at least one year, and a control group (n = 15) with no structured exercise history. Venous blood samples were collected after overnight fasting. Serum IMA was quantified using the albumin-cobalt binding assay, and -SH concentrations were determined via the Ellman method. All analyses were performed in duplicate under standardized laboratory conditions. Independent samples t-tests were applied, and effect sizes (Cohen's d) were calculated with 95% confidence intervals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 20, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2022

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2022

Completed
3.5 years until next milestone

First Submitted

Initial submission to the registry

September 4, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 18, 2025

Completed
Last Updated

September 23, 2025

Status Verified

September 1, 2025

Enrollment Period

1 month

First QC Date

September 4, 2025

Last Update Submit

September 22, 2025

Conditions

Keywords

Ischemia-Modified AlbuminTotal Sulfhydryl GroupsOxidative Stress BiomarkersRedox RemodelingAntioxidant Capacity

Outcome Measures

Primary Outcomes (1)

  • Serum Ischemia-Modified Albumin (IMA)

    Change in serum ischemia-modified albumin (IMA) concentration, measured in absorbance units (ABSU) using the albumin-cobalt binding assay.

    Baseline (single fasting blood draw)

Secondary Outcomes (1)

  • Serum Total Sulfhydryl Groups (-SH)

    Baseline (single fasting blood draw)

Study Arms (2)

Exercising Women

Healthy women aged 18-25 years who performed structured exercise training ≥3 sessions per week for at least 12 months. Training programs included aerobic, resistance, and flexibility exercise, each session lasting 60-90 minutes.

Sedentary Controls

Healthy women aged 18-25 years without a history of structured exercise. Physical activity limited to daily living and compulsory school-based physical education classes.

Eligibility Criteria

Age18 Years - 25 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Thirty healthy women aged 18-25 years were recruited. Fifteen had a history of regular structured exercise training, while fifteen had sedentary lifestyles without structured exercise.

You may qualify if:

  • Healthy women aged 18-25 years
  • For exercise group: Regular structured training ≥3 sessions per week for at least 12 months
  • For control group: No structured exercise background, only daily living activity

You may not qualify if:

  • History of chronic cardiovascular, metabolic, or endocrine disorders
  • Smoking or alcohol abuse
  • Current or recent use (past 6 months) of medications or supplements influencing oxidative stress or hormonal regulation
  • Irregular or intermittent exercise participation not meeting the defined threshold

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yüzüncü Yıl University, Central Research Laboratory

Van, Muş, 49100, Turkey (Türkiye)

Location

Related Publications (1)

  • Bilici OF, Kahraman MZ, Turker A, Seyhan S, Sahin MF, Demir H, Acar G, Bilici MF, Soylu C, Sogut T, Bakum A. Effects of regular exercise on ischemia-modified albumin and total sulfhydryl levels in young women: a cross-sectional study. Front Physiol. 2025 Nov 20;16:1719454. doi: 10.3389/fphys.2025.1719454. eCollection 2025.

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 4, 2025

First Posted

September 18, 2025

Study Start

January 20, 2022

Primary Completion

February 20, 2022

Study Completion

March 20, 2022

Last Updated

September 23, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared because the study involved a small sample of healthy young women and includes sensitive biomarker information. Data sharing is restricted by the ethics committee approval and participant consent, which did not authorize public distribution of individual-level data.

Locations